Healthcare provider profile · identity verified

Kerry D Leichty

Family Practice · HARRISONBURG, VA · NPI 1720080161

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	955	272
Amlodipine Besylate	Amlodipine Besylate	687	170
Levothyroxine Sodium	Levothyroxine Sodium	538	149
Lisinopril	Lisinopril	484	147
Rosuvastatin Calcium	Rosuvastatin Calcium	438	131
Losartan Potassium	Losartan Potassium	406	125
Hydrochlorothiazide	Hydrochlorothiazide	338	98
Omeprazole	Omeprazole	311	103
Tamsulosin Hcl	Tamsulosin Hcl	296	87
Metoprolol Succinate	Metoprolol Succinate	290	84
Sertraline Hcl	Sertraline Hcl	286	73
Metformin Hcl	Metformin Hcl	282	89
Gabapentin	Gabapentin	274	65
Simvastatin	Simvastatin	258	81
Pantoprazole Sodium	Pantoprazole Sodium	234	59
Furosemide	Furosemide	228	75
Carvedilol	Carvedilol	227	64
Pravastatin Sodium	Pravastatin Sodium	223	59
Eliquis	Apixaban	222	43
Potassium Chloride	Potassium Chloride	208	45
Ezetimibe	Ezetimibe	201	53
Alprazolam	Alprazolam	174	48
Duloxetine Hcl	Duloxetine Hcl	169	40
Zolpidem Tartrate	Zolpidem Tartrate	164	28
Metformin Hcl Er	Metformin Hcl	158	49
Metoprolol Tartrate	Metoprolol Tartrate	151	49
Glimepiride	Glimepiride	128	35
Meloxicam	Meloxicam	126	45
Allopurinol	Allopurinol	119	29
Citalopram Hbr	Citalopram Hydrobromide	119	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	119	29
Montelukast Sodium	Montelukast Sodium	115	33
Synthroid	Levothyroxine Sodium	103	28
Finasteride	Finasteride	99	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	95	27
Trazodone Hcl	Trazodone Hcl	94	32
Olmesartan Medoxomil	Olmesartan Medoxomil	92	20
Atenolol	Atenolol	89	20
Clopidogrel	Clopidogrel Bisulfate	82	27
Prednisone	Prednisone	77	58
Mirtazapine	Mirtazapine	74	12
Alendronate Sodium	Alendronate Sodium	71	24
Escitalopram Oxalate	Escitalopram Oxalate	71	22
Cephalexin	Cephalexin	69	56
Donepezil Hcl	Donepezil Hcl	64	14
Clonazepam	Clonazepam	63	18
Ozempic	Semaglutide	63	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	63	13
Azithromycin	Azithromycin	60	55
Paroxetine Hcl	Paroxetine Hcl	60	14
Jardiance	Empagliflozin	59	15
Diclofenac Sodium	Diclofenac Sodium	57	21
Famotidine	Famotidine	55	16
Warfarin Sodium	Warfarin Sodium	54	17
Bupropion Hcl Sr	Bupropion Hcl	53	13
Lovastatin	Lovastatin	52	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	51	47
Solifenacin Succinate	Solifenacin Succinate	50	11
Venlafaxine Hcl Er	Venlafaxine Hcl	50	14
Amitriptyline Hcl	Amitriptyline Hcl	49	14
Glipizide Er	Glipizide	48	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	13
Doxycycline Hyclate	Doxycycline Hyclate	46	36
Farxiga	Dapagliflozin Propanediol	46	suppressed
Irbesartan	Irbesartan	46	suppressed
Spironolactone	Spironolactone	45	22
Terazosin Hcl	Terazosin Hcl	45	15
Cefuroxime	Cefuroxime Axetil	44	38
Fluticasone Propionate	Fluticasone Propionate	44	11
Benazepril Hcl	Benazepril Hcl	42	13
Celecoxib	Celecoxib	38	12
Bupropion Xl	Bupropion Hcl	37	11
Xarelto	Rivaroxaban	36	11
Albuterol Sulfate Hfa	Albuterol Sulfate	35	21
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	34	suppressed
Amoxicillin	Amoxicillin	33	22
Lorazepam	Lorazepam	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	12
Chlorthalidone	Chlorthalidone	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Trulicity	Dulaglutide	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Dutasteride	Dutasteride	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	23
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Nystatin	Nystatin	27	19
Premarin	Estrogens, Conjugated	27	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	26	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	11
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	21
Triamcinolone Acetonide	Triamcinolone Acetonide	26	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Labetalol Hcl	Labetalol Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Fluconazole	Fluconazole	23	11
Ipratropium Bromide	Ipratropium Bromide	23	13
Torsemide	Torsemide	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Ondansetron Odt	Ondansetron	22	11
Telmisartan	Telmisartan	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Mounjaro	Tirzepatide	19	suppressed
Nitroglycerin	Nitroglycerin	19	11
Repatha Sureclick	Evolocumab	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Topiramate	Topiramate	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	suppressed
Primidone	Primidone	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Fosinopril Sodium	Fosinopril Sodium	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	15	suppressed
Acarbose	Acarbose	14	suppressed
Diazepam	Diazepam	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Mupirocin	Mupirocin	14	14
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	13	13
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	12
Pregabalin	Pregabalin	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	11	suppressed
Glipizide	Glipizide	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error